Olynth Combo 1 mg/ml + 50 mg/ml sprej za nos, otopina
| Name | Olynth Combo 1 mg/ml + 50 mg/ml sprej za nos, otopina |
|---|---|
| Marketing Authorisation Number | HR-H-202956797 |
| Active Substance | ksilometazolinklorid dekspantenol |
| Composition | 1 ml spreja za nos, otopine, sadrži 1 mg ksilometazolinklorida i 50 mg dekspantenola |
| Pharmaceutical Form | sprej za nos, otopina |
| Manufacturer | Famar Health Care Services Madrid S.A.U., Alcorcon, Madrid, Španjolska Ursapharm Arzneimittel GmbH, Saarbrücken, Njemačka |
| Marketing Authorisation Holder | McNeil Healthcare (Ireland) Limited, Tallaght, High Street, Office 5, 6 & 7, Block 5, Dublin, Irska |
| Marketing Authorisation Date | 27.12.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/42 |
| Registration Number | 381-12-01/14-23-17 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | allowed |
| ATC Code | R01AB06 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
